Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1999
06/17/1999WO1999029883A2 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease
06/17/1999WO1999029882A2 Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins
06/17/1999WO1999029881A1 Genetic method
06/17/1999WO1999029880A2 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors
06/17/1999WO1999029879A1 VEGETABLE GntI SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY
06/17/1999WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999WO1999029877A1 Methods for defining cell types
06/17/1999WO1999029876A2 Mutant bacillus licheniformis alpha-amylase
06/17/1999WO1999029875A2 Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
06/17/1999WO1999029874A1 Methods for increasing hemoprotein production in fungal mutants
06/17/1999WO1999029873A1 Cyclic gmp phosphodiesterase
06/17/1999WO1999029872A1 Nucleic acid molecules encoding canine parainfluenza type 2f and hn proteins
06/17/1999WO1999029871A2 Circovirus sequences related to piglet weight loss disease (pwd)
06/17/1999WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999WO1999029869A1 Compounds and methods for the diagnosis and treatment of b. microti infection
06/17/1999WO1999029868A1 VACCINES FOR BLOCKING TRANSMISSION OF $i(PLASMODIUM VIVAX)
06/17/1999WO1999029867A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
06/17/1999WO1999029866A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof
06/17/1999WO1999029865A2 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
06/17/1999WO1999029864A1 Recombinant vaccinia constructs expressing feline il-2, compositions and methods of use thereof
06/17/1999WO1999029863A1 Human interferon-epsilon: a type i interferon
06/17/1999WO1999029862A1 Synferon, a synthetic type i interferon
06/17/1999WO1999029861A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029859A1 Gene associated with neoplastic disease or malignancy associated gene
06/17/1999WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999WO1999029857A1 Two sterile-20 kinase-like proteins and methods of use thereof
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029854A1 Human patched genes and proteins, and uses related thereto
06/17/1999WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029852A1 High-affinity tryptophan transporter
06/17/1999WO1999029851A1 Human 'kismet' protein hkis acts as a tumor suppressor
06/17/1999WO1999029850A1 HUMAN KISMET PROTEIN (hkis) ACTS AS AN ONCOGENE
06/17/1999WO1999029849A1 G-protein coupled receptors associated with immune response
06/17/1999WO1999029848A1 Novel vectors and genes exhibiting increased expression
06/17/1999WO1999029847A1 T-type voltage-gated calcium channels and method of using same
06/17/1999WO1999029846A1 Transgenic mice expressing the h/k-ras 4b chimeric gene
06/17/1999WO1999029845A1 SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS
06/17/1999WO1999029844A2 Novel retroelements zam and idemfix, and their integrase
06/17/1999WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999WO1999029842A1 Nucleic acid mediated rna tagging and rna revision
06/17/1999WO1999029841A1 Purification and microsequencing of hyaluronidase isozymes
06/17/1999WO1999029840A1 Methods of nucleic acid isolation
06/17/1999WO1999029839A1 Grafted copolymers as gene carriers
06/17/1999WO1999029838A1 Fibrinogen-converting enzyme hybrids
06/17/1999WO1999029837A2 Novel dna cloning method relying on the e. coli rece/rect recombination system
06/17/1999WO1999029834A1 Methods for preparation of vaccines against cancer
06/17/1999WO1999029833A1 Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
06/17/1999WO1999029832A1 Method for purifying plasmid dna and plasmid dna substantially free of genomic dna
06/17/1999WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999WO1999029728A1 Method and composition to enhance the efficacy of a vaccine using chemokines
06/17/1999WO1999029725A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5
06/17/1999WO1999029723A1 Recombinant nodavirus compositions and methods
06/17/1999WO1999029722A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4
06/17/1999WO1999029721A1 Anti-pathogen system and methods of use thereof
06/17/1999WO1999029720A2 Mammalian alpha helical protein-1
06/17/1999WO1999029718A2 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999WO1999029715A1 Tumor antigen peptide derivatives
06/17/1999WO1999029712A1 Peptide-based gemini compounds
06/17/1999WO1999029711A1 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
06/17/1999WO1999029703A2 Isolation of nucleic acids
06/17/1999WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999WO1999029342A1 Vaccines containing attenuated bacteria
06/17/1999WO1999029341A2 Methods for enhancement of protective immume responses employing leishmania polypeptides
06/17/1999WO1999029340A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999WO1999029310A2 Regulation of t cell-mediated immunity by tryptophan and its analogs
06/17/1999WO1999029303A1 Biodegradable mixed polymeric micelles for gene delivery
06/17/1999WO1999029161A1 A starchless variety of pisum sativum having elevated levels of sucrose
06/17/1999WO1999029160A1 STRAIN MANIPULATION AND IMPROVEMENT IN THE EDIBLE SEAWEED $i(PORPHYRA)
06/17/1999WO1999029159A1 Plant senescence-associated genes
06/17/1999WO1999019358A3 Antibody against baculoviruses
06/17/1999WO1999018216A3 Chimeric vaccine against tick-borne encephalitis virus
06/17/1999WO1999017796A3 Modulation of lerk-2-mediated cell adhesion
06/17/1999WO1999016887A3 Compositions and methods for identifying pkb kinase inhibitors
06/17/1999WO1999016883A3 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN
06/17/1999WO1999015682A3 Gene silencing materials and methods
06/17/1999WO1999015554A3 Ras-like protein
06/17/1999WO1999015549A3 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
06/17/1999WO1999015548A3 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
06/17/1999WO1999015009A9 TRYPSIN INHIBITORS WITH INSECTICIDAL PROPERTIES OBTAINED FROM $i(PENTACLETHRA MACROLOBA)
06/17/1999WO1999013064A3 Viral infection of cells using viral vectors
06/17/1999WO1999011783A3 T-box polypeptides
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1999007844A3 Methods and compositions for treatment of restenosis
06/17/1999WO1999005319A9 Methods and compounds for analyzing nucleic acids by mass spectrometry
06/17/1999WO1999004237A3 Diagnosis of spongiform encephalopathies using prionins
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999WO1998033901A3 Generation of diversity in combinatorial libraries
06/17/1999DE19755302A1 Neuer Transkriptionsfaktor CPCR1 zur Regulation des Isopenicillin N-Synthetase-Gens (pcbC) und des AC-/ACV-Synthetase-Gens (pcbAB) CPCR1 new transcription factor in the regulation of the isopenicillin N synthetase gene (pcbC) and the AC / ACV synthetase gene (pcbAB)
06/17/1999DE19754929A1 Verfahren zur Herstellung transgener Pflanzen mit veränderter 5-Aminolävulinsäure-Biosynthese und Verfahren zur Identifizierung von Effektoren der 5-Aminolävulinsäure Synthese A method for producing transgenic plants with altered 5-aminolevulinic acid biosynthesis and method for identifying effectors of 5-aminolevulinic acid synthesis
06/17/1999DE19754774A1 Transgenes nicht-menschliches Säugetier mit einer onkogenen Mutante des Raf-1-Gens A transgenic non-human mammal with an oncogenic mutant of the Raf-1 gene
06/17/1999CA2759882A1 Novel dna cloning method
06/17/1999CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999CA2318476A1 Plant senescence-associated genes
06/17/1999CA2318306A1 Isolation of nucleic acids
06/17/1999CA2317806A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999CA2315273A1 Dna molecules encoding vertebrate nuclear receptor protein, nnr4